We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+17.13%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$31.9B
AUM Growth
+$4.19B
Cap. Flow
+$23.1M
Cap. Flow %
0.07%
Top 10 Hldgs %
18.87%
Holding
1,397
New
111
Increased
494
Reduced
445
Closed
146

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$83.9M
2
QDEL icon
QuidelOrtho
QDEL
+$75.7M
3
GXC icon
State Street SPDR S&P China ETF
GXC
+$73.7M
4
TSLA icon
Tesla
TSLA
+$58.1M
5
MSFT icon
Microsoft
MSFT
+$48.7M

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$149M
2
HON icon
Honeywell
HON
+$72.2M
3
IBM icon
IBM
IBM
+$66M
4
INTC icon
Intel
INTC
+$63.3M
5
LMND icon
Lemonade
LMND
+$56M

Sector Composition

Rank Sector Weight
1 Technology 31.17%
2 Healthcare 17.83%
3 Consumer Discretionary 11.58%
4 Financials 10.55%
5 Industrials 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AES icon
701
AES
AES
$10.6B
$4.22M 0.01%
179,464
+10,368
+6% +$215K
LNC icon
702
Lincoln National
LNC
$8.32B
$4.21M 0.01%
83,628
-32,281
-28% -$1.37M
FHN icon
703
First Horizon
FHN
$11.6B
$4.19M 0.01%
328,400
UPBD icon
704
Upbound Group
UPBD
$1.03B
$4.18M 0.01%
+109,300
New +$3.71M
LMNR icon
705
Limoneira
LMNR
$238M
$4.18M 0.01%
251,065
+22,283
+10% +$335K
IEFA icon
706
iShares Core MSCI EAFE ETF
IEFA
$193B
$4.17M 0.01%
60,348
-1,136
-2% -$73.5K
NTR icon
707
Nutrien
NTR
$37.6B
$4.16M 0.01%
86,300
-2,086
-2% -$92.2K
PNFP icon
708
Pinnacle Financial Partners Inc
PNFP
$15B
$4.15M 0.01%
+64,500
New +$3.33M
CRWD icon
709
CrowdStrike
CRWD
$248B
$4.12M 0.01%
77,784
-976
-1% -$38K
CBT icon
710
Cabot Corp
CBT
$4.09B
$4.07M 0.01%
90,566
+15,100
+20% +$627K
CIXX
711
DELISTED
CI Financial Corp.
CIXX
$4.03M 0.01%
+324,342
New +$4.21M
J icon
712
Jacobs Solutions
J
$17B
$4.01M 0.01%
44,499
+1,194
+3% +$101K
MUSA icon
713
Murphy USA
MUSA
$9.67B
$4M 0.01%
30,600
-7,700
-20% -$989K
BILL icon
714
BILL Holdings
BILL
$4.26B
$4M 0.01%
+29,300
New +$3.46M
SHOP icon
715
Shopify
SHOP
$167B
$3.95M 0.01%
34,860
+5,010
+17% +$526K
HP icon
716
Helmerich & Payne
HP
$4.34B
$3.89M 0.01%
167,802
-38,698
-19% -$750K
ADI icon
717
Analog Devices
ADI
$175B
$3.87M 0.01%
26,201
+22,098
+539% +$2.93M
ATRA icon
718
Atara Biotherapeutics
ATRA
$94.8M
$3.87M 0.01%
7,882
-128
-2% -$59.1K
GEO icon
719
The GEO Group
GEO
$4.11B
$3.86M 0.01%
435,500
-3,600
-0.8% -$34.5K
REZI icon
720
Resideo Technologies
REZI
$2.84B
$3.83M 0.01%
180,015
+142,967
+386% +$2.29M
PB icon
721
Prosperity Bancshares
PB
$8.53B
$3.8M 0.01%
54,800
HZO icon
722
MarineMax
HZO
$1.16B
$3.8M 0.01%
108,400
BHVN
723
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$3.8M 0.01%
44,295
-23,809
-35% -$2.02M
CNXN icon
724
PC Connection
CNXN
$2.15B
$3.77M 0.01%
79,714
-1,800
-2% -$82.7K
SFM icon
725
Sprouts Farmers Market
SFM
$6.85B
$3.76M 0.01%
187,071
+2,206
+1% +$45.2K

Similar funds

Axa's Q4 2020 Portfolio in Review

As of Q4 2020, Axa held 1,397 positions worth $31.9B, up 15% from $27.7B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Axa's Q4 2020 filing shows 111 new, 494 increased, 445 reduced and 146 closed positions. Its largest new stake was State Street SPDR S&P China ETF: 580,524 shares worth $75.6M. The largest sale was Linde, an estimated $149M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Axa's largest Q4 2020 buy was State Street SPDR S&P China ETF: 580,524 shares worth $75.6M.
  • Axa added most to Amazon in Q4 2020, an estimated $83.9M increase.
  • Axa's biggest Q4 2020 reduction was Linde, cutting an estimated $149M.
  • Axa fully exited Jumia Technologies in Q4 2020, selling an estimated $42.2M.
  • Axa's ten largest holdings make up 19% of its $31.9B portfolio in Q4 2020.
  • Axa opened 111 new positions and closed 146 in Q4 2020.
  • Axa's portfolio value rose 15% quarter-over-quarter to $31.9B.

Based on Axa's 13F filing for Q4 2020, filed 12 Feb 2021.